Elevated systemic galectin-1 levels characterize HELLP syndrome
- 1 April 2016
- journal article
- clinical trial
- Published by Elsevier in Journal of Reproductive Immunology
- Vol. 114, 38-43
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (BL1115/2-1)
- Fritz Thyssen Stiftung
This publication has 36 references indexed in Scilit:
- The course of angiogenic factors in early- vs. late-onset preeclampsia and HELLP syndromeJournal of Perinatal Medicine, 2013
- Galectin-1 Is Part of Human Trophoblast Invasion Machinery - A Functional Study In VitroPLOS ONE, 2011
- Human Decidual NK Cells from Gravid Uteri and NK Cells from Cycling Endometrium are Distinct NK Cell SubsetsPlacenta, 2010
- The role of p38α mitogen-activated protein kinase gene in the HELLP syndromeCell Stress and Chaperones, 2010
- Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) Functions to Promote Uterine Decidual Angiogenesis during Early Pregnancy in the MouseEndocrinology, 2009
- The HELLP syndrome: Clinical issues and management. A ReviewBMC Pregnancy and Childbirth, 2009
- T cell apoptosis at the maternal–fetal interface in early human pregnancy, involvement of galectin-1Proceedings of the National Academy of Sciences, 2008
- Preterm Birth in Caucasians Is Associated with Coagulation and Inflammation Pathway Gene VariantsPLOS ONE, 2008
- HELLP SyndromeClinical Obstetrics and Gynecology, 1999
- Maternal haemolysis, elevated liver enzymes and low platelets syndrome: Specific problems in the newbornEuropean Journal of Pediatrics, 1993